Richard Malamut
Director · Pelthos Therapeutics Inc.
- 2024
- Apr 6, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard Malamut files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd C. Davis - $1000K in PTHS purchases and sales in the last 12 months
- Ezra M. Friedberg - $326K in PTHS purchases and sales in the last 12 months
- Peter Greenleaf - $54K in PTHS purchases and sales in the last 12 months
- Matthew Pauls - $54K in PTHS purchases and sales in the last 12 months
- Knuettel Francis II - $40K in PTHS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard Malamut?
Richard Malamut is a corporate insider, tracked as Director of Pelthos Therapeutics Inc. (PTHS). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Richard Malamut last file a Form 4?
The most recent primary Form 4 on record is dated 6 April 2026, one of 4 filings going back to 2024.
Has Richard Malamut been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($12K) across all tracked filings.
